CD44 and cancer: Similar observations have been made for other cancer models including gastric 91, breast 92, head and neck squamous cell carcinoma 65 and lung 66 tumors, reinforcing the influence of CD44 as a co-regulator of RTK signaling and EGFR mediated pathways, thereby contributing to cell proliferation and invasion.